(Q71739934)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

Stephens S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Emtage S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Vetterlein O

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Chaplin L

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Bebbington C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Nesbitt A

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Sopwith M

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Athwal D

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Novak C

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Bodmer M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

668-674

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7558164%20AND%20SRC:MED&resulttype=core&format=json

A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties

20 October 2019

cites work

1 reference

12 December 2020

Polymerase chain reaction facilitates the cloning, CDRgrafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins

1 reference

12 December 2020

Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys

1 reference

12 December 2020

Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans

1 reference

12 December 2020

Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis

1 reference

12 December 2020

Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints

1 reference

12 December 2020

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

12 December 2020

Engineering antibodies for therapy

1 reference

12 December 2020

Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea

1 reference

12 December 2020

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

12 December 2020

The dosage requirements for immunological paralysis by soluble proteins

1 reference

12 December 2020

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

12 December 2020

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

12 December 2020

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

12 December 2020

Human immune response to monoclonal antibody administration is dose-dependent

1 reference

12 December 2020

Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1

1 reference

12 December 2020

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

12 December 2020

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

1 reference

12 December 2020

The immunogenicity of chimeric antibodies

1 reference

12 December 2020

Monoclonal antibody to TNF in severe septic shock

1 reference

12 December 2020

The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.

1 reference

12 December 2020

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

12 December 2020

Identifiers

1 reference